Publications

5808 Results

Estrogen receptor methylation is a favorable prognostic factor in AML.

Authors
JJ Issa;KJ Kopecky;F Appelbaum;C Willman;SB Baylin
Journal / Conference
American Society of Clinical Oncology 15:357(#1048)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8706

The prostate cancer prevention trial: Efforts to increase the recruitment of minority participants.

Authors
CM Moinpour
Journal / Conference
Poster for Conf on the Recruit and Retention of Min Parts in CCR 1/26-27/96 :
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

CHOP plus radiotherapy (RT) is superior to CHOP alone for adjuvant therapy of resected localized unfavorable non-Hodgkin's lymphoma (NHL).

Authors
TP Miller;S Dahlberg;JR Cassady;C Spier;TM Grogan;S Carlin;E Chase;RI Fisher
Journal / Conference
Proc 8th Intl Conf on the Adjuvant Therapy of Cancer :47(#27)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

Infusional therapy with first generation chemosensitizers (CS) results in increased toxicity without improved benefit in untreated lymphoma.

Authors
ER Gaynor;TP Miller;S Dahlberg;M LeBlanc;RI Fisher
Journal / Conference
American Society of Clinical Oncology 15:413(#1265)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9125, SWOG-9240

Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group study.

Authors
TR Fleming;TD Brown;SW Ross;JS Macdonald
Journal / Conference
Investigational New Drugs 13:363-365
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8721

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated wtih carmustine.

Authors
M Belanich;M Pastor;T Randall;D Guerra;J Kibitel;L Alas;B Li;M Citron;P Wasserman;A White;H Eyre;K Jaeckle;S Schulman;D Rector;M Prados;S Coons;W Shapiro;D Yarosh
Journal / Conference
Cancer Research 56(4):783-788
Year
1996
Research Committee(s)
Brain
Study Number(s)
SWOG-9218

Intraperitoneal cislatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;JA Young;EW Franklin;DL Clarke-Pearson;VK Malviya;B DuBeshter;MD Adelson;WJ Hoskins
Journal / Conference
New England Journal of Medicine 335(26):1950-1955
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

Prostate cancer prevention trial.

Authors
BH Zoltick
Journal / Conference
Presented at the AUAA Annual Assembly-Orlando Florida May 4-7 :
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Screening for prostate cancer: Opportunities for prevention.

Authors
IM Thompson;CA Coltman Jr
Journal / Conference
Seminars in Urologic Oncology 14(2)(Suppl.2):4-11
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Chemoprevention of prostate cancer with finasteride.

Authors
I Thompson;P Feigl;C Coltman
Journal / Conference
Principles and Practice of Oncology 10(3):1-18
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217